This table shows a summary of the binding experiments that are available in this release. For each factor, the number of primary peaks at the 1% and 25% FDR cutoff are shown for both the Symmetric-null test and the experimental IgG (mock) IP test. For factors with two antibodies, the overlap is shown as the percentage of the 1% FDR primary peaks for one antibody that are within 500bp of a 25% FDR primary peak from the other antibody.
To access the data, either select from the drop down or click on the antibody name in the table:
| Transcription Factor |
Classification | Antibodies | Symmetric-null Test | Experimental IgG IP Test | ||||
| Number of Primary Peaks | Antibody % Overlap |
Number of Primary Peaks | Antibody % Overlap |
|||||
| 1% FDR | 25% FDR | 1% FDR | 25% FDR | |||||
| bcd | maternal | Anti-bcd(1) | 619 | 3295 | 89.01% | 559 | 1276 | 86.76% |
| Anti-bcd(2) | 702 | 3404 | 88.75% | 543 | 1070 | 88.95% | ||
| cad | maternal | Anti-cad(1) | 1591 | 6326 | N/A | 1115 | 5109 | N/A |
| gt | gap | Anti-gt(2) | 1070 | 3968 | N/A | 980 | 3973 | N/A |
| hb | gap | Anti-hb(1) | 1832 | 4707 | 80.51% | 1867 | 3954 | 74.40% |
| Anti-hb(2) | 1718 | 6675 | 83.12% | 1259 | 2540 | 84.91% | ||
| kni | gap | Anti-kni(1) | 36 | 330 | 94.44% | 119 | 527 | 96.64% |
| Anti-kni(2) | 197 | 5167 | 85.79% | 204 | 794 | 91.67% | ||
| Kr | gap | Anti-Kr(1) | 3592 | 11323 | 81.99% | 2623 | 5250 | 86.85% |
| Anti-Kr(2) | 4084 | 12255 | 82.76% | 2622 | 4832 | 87.41% | ||
| RNA pol II, unphorphorylated |
general | 8WG16 | 4534 | 11811 | N/A | 3830 | 5081 | N/A |
| RNA pol II, phorphorylated |
general | H14 | 3022 | 7992 | N/A | 202 | 530 | N/A |
| Z | transcription factor |
Anti-Z(3) | 1428 | 8034 | N/A | 202 | 530 | N/A |